the basis of the following characteristics: catalase negativity, α-hemolytic gram-positive cocci forming pairs and tetrads (not chains) in broth culture; growth in the presence of 40% bile and 6.5% NaCl and ability to hydrolyze esculin; pyrrolidony l-aminopeptidase positivity, leucineaminopeptidase negativity; and production of acid from trehalose, sucrose, maltose, and lactose but not from sorbitol.
Susceptibility testing by the agar dilution method showed that the isolate was susceptible to penicillin-G (MIC = 0.12 µg/ml) and vancomycin (MIC = 0.25 µg/ml). On the basis of this case and previous reports (1,2), we believe that A. viridans is a potential pathogen that can cause serious infections in immunocompromised patients. The presumed route of infection in this patient was esophageal ulcers. Clinical microbiologists should pay close attention to α-hemolytic, catalasenegative streptococci recovered from sterile body sites that form tetrads rather than chains on Gram stain.
Proficiency in Detecting Vancomycin Resistance in Enterococci among Clinical Laboratories in Santiago, Chile
To the Editor: Vancomycin-resistant enterococci (VRE) can be difficult to detect because of limitations in the susceptibility testing methods commonly used in clinical laboratories. Although VRE have not been reported in Chile, clinical isolates have been reported in Argentina (1) and Brazil (2) . It is important to detect vancomycin resistance as early as possible, so infection control preventive measures can be instituted when they have their greatest impact. The microbiology laboratory is the first line of defense against VRE, as it plays a critical role in its recognition. In Chile, most laboratories follow the National Committee for Clinical Laboratory Standards recommendations for antimicrobial susceptibility testing and use disk-diffusion methods (3); however, these methods have limitations in detecting low levels of resistance to vancomycin in enterococci.
We evaluated the ability of referral microbiology laboratories in Chile to detect vancomycin resistance in five Enteroccocus spp. isolates with different susceptibility patterns for vancomycin, penicillin, and ampicillin. Of six referral laboratories that agreed to participate, four used the disk-diffusion method to evaluate antimicrobial susceptibility. Two used an agar dilution minimum inhibitory concentration (MIC) method, one as the only susceptibility testing method and the other in addition to disk diffusion. The participants correctly evaluated vancomycin susceptibility in 17 (57%) of 30 isolates.
The accuracy of detecting vancomycin resistance varied according to the level of resistance. Isolate 1, which had a high level of resistance (Van A phenotype, MIC 256 µg/ml), was evaluated correctly in 5 (83%) of 6 laboratories. Isolate 2, with a lower level of resistance (Van B, MIC 64 µg/ml), was evaluated correctly in 4 (67%) of 6 laboratories. Isolates 3 and 4, both with intermediate resistance (Van B, MIC 16-32 µg/ml, and Van C, MIC 8 µg/ml, respectively), were evaluated correctly by one laboratory each. 
faecalis).
The results of this study are consistent with those of previous studies in the United States (4, 5) , South America (6), Spain (7), and Mexico (8) . Although in countries like Chile, disk diffusion is practical and reliable for most susceptibility testing, detecting low-level vancomycin resistance in enterocci is difficult without supplementary testing. In Chile, as in other countries, strategies should be implemented to improve detection of these strains, including improvement of phenotypical and genotypical methods for VRE detection and species identification. Documentation of proficiency in detecting VRE is important for improving laboratory performance, detecting clinical isolates, and accurate and reliable reporting to local, national, and international surveillance systems.
